{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:54:29Z","timestamp":1772780069671,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017647","name":"ResMed","doi-asserted-by":"publisher","award":["Unrestricted grant"],"award-info":[{"award-number":["Unrestricted grant"]}],"id":[{"id":"10.13039\/100017647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11325-025-03517-7","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:57:39Z","timestamp":1761235059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing new treatments for central sleep Apnoea in heart failure: sample size considerations for reliable detection of safety signals"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6588-5039","authenticated-orcid":false,"given":"Holger","family":"Woehrle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Wegscheider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita K.","family":"Simonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Arzt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Louis","family":"P\u00e9pin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Heinzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Cistulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam V.","family":"Benjafield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eik","family":"Vettorazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"Cowie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"3517_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00959-2016","author":"W Randerath","year":"2017","unstructured":"Randerath W, Verbraecken J, Andreas S (2017) Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.00959-2016","journal-title":"Eur Respir J"},{"key":"3517_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jsmc.2007.08.001","volume":"2","author":"P L\u00e9vy","year":"2007","unstructured":"L\u00e9vy P, P\u00e9pin J-L, Tamisier R (2007) Prevalence and impact of central sleep apnea in heart failure. Sleep Med Clin 2:615\u2013621","journal-title":"Sleep Med Clin"},{"key":"3517_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejheart.2006.08.003","volume":"9","author":"O Oldenburg","year":"2007","unstructured":"Oldenburg O, Lamp B, Faber L et al (2007) Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 9:251\u2013257","journal-title":"Eur J Heart Fail"},{"key":"3517_CR4","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.sleep.2008.08.004","volume":"10","author":"O Oldenburg","year":"2009","unstructured":"Oldenburg O, Bitter T, Wiemer M (2009) Pulmonary capillary wedge pressure and pulmonary arterial pressure in heart failure patients with sleep-disordered breathing. Sleep Med 10:726\u2013730","journal-title":"Sleep Med"},{"key":"3517_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/hrt.2008.160952","volume":"95","author":"D Yumino","year":"2009","unstructured":"Yumino D, Wang H, Floras JS (2009) Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart 95:819\u2013824","journal-title":"Heart"},{"key":"3517_CR6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1056\/NEJMoa1506459","volume":"373","author":"MR Cowie","year":"2015","unstructured":"Cowie MR, Woehrle H, Wegscheider K et al (2015) Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 373:1095\u20131105","journal-title":"N Engl J Med"},{"key":"3517_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S2213-2600(23)00374-0","volume":"12","author":"TD Bradley","year":"2024","unstructured":"Bradley TD, Logan AG, Lorenzi Filho G et al (2024) Adaptive servo-ventilation for sleep-disordered breathing in patients with heart failure with reduced ejection fraction (ADVENT-HF): a multicentre, multinational, parallel-group, open-label, phase 3 randomised controlled trial. Lancet Respir Med 12:153\u2013166","journal-title":"Lancet Respir Med"},{"key":"3517_CR8","unstructured":"U.S. Food and Drug Administration. Guidance for Industry. Diabetes mellitus - evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes (Dec 2008)"},{"key":"3517_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S2213-2600(23)00377-6","volume":"12","author":"SR Patel","year":"2024","unstructured":"Patel SR, Sykes AV, Malhotra A (2024) Sleep apnoea in congestive heart failure: one step forwards. Lancet Respir Med 12:94\u201396","journal-title":"Lancet Respir Med"},{"key":"3517_CR10","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995\u20132008","journal-title":"N Engl J Med"},{"key":"3517_CR11","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1001\/jama.2020.1906","volume":"323","author":"MC Petrie","year":"2020","unstructured":"Petrie MC, Verma S, Docherty KF et al (2020) Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes. JAMA 323:1353\u20131368","journal-title":"JAMA"},{"key":"3517_CR12","first-page":"e895","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D et al (2022) 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of Cardiology\/American heart association joint committee on clinical practice guidelines. Circulation 145:e895\u2013e1032","journal-title":"Circulation"},{"key":"3517_CR13","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599\u20133726","journal-title":"Eur Heart J"},{"key":"3517_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.15420\/cfr.2017:7:1","volume":"3","author":"A Valika","year":"2017","unstructured":"Valika A, Costanzo MR (2017) Sleep-disordered breathing during congestive heart failure: to intervene or not to intervene? Card Fail Rev 3:134\u2013139","journal-title":"Card Fail Rev"},{"key":"3517_CR15","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/europace\/eur128","volume":"13","author":"J Lamba","year":"2011","unstructured":"Lamba J, Simpson CS, Redfearn DP et al (2011) Cardiac resynchronization therapy for the treatment of sleep apnoea: a meta-analysis. Europace 13:1174\u20131179","journal-title":"Europace"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-025-03517-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11325-025-03517-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-025-03517-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:56:46Z","timestamp":1765810606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11325-025-03517-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1007\/s11325-025-03517-7","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Comit\u00e9 de Protection des Personnes Sud-Est V (ref : CPP-08-RESM-01) approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"HW reports lecture\/consulting fees from Astra Zeneca, Allergopharma, Bioprojet, Boehringer Ingelheim, Chiesi, GSK, Novartis, Inspire, Jazz and ResMed, and research support from ResMed and Novartis. KW has no conflict of interest. AKS has received speaker and travel fees from ResMed. MA has received grant support from ResMed, the ResMed Foundation, Philips Respironics, the Else-Kroehner Fresenisus Foundation, and the Federal Ministry of Education and Research (BMBF), and has received lecture and consulting fees from ResMed, Philips Respironics, Inspire Medical Systems, Zoll Respicardia and Eli Lilly, all outside the submitted work. JLP is supported by the French National Research Agency in the framework of the Investissements d\u2019Avenir program [Grant ANR-15-IDEX-02] and the e-Health and Integrated Care and Trajectories Medicine, and MIAI Artificial Intelligence chairs of excellence from the Grenoble Alpes University Foundation (ANR-19-P3IA-0003). JLP also reports lecture fees or conference travel grants from ResMed, Philips, Jazz Pharmaceuticals, Agiradom, and Bioprojet. PL has no conflict of interest. RH has received speaker or consultancy fees from ResMed, Jazz Pharmaceuticals, Inspire Medical Systems, Bioprojet, Philips, Merck, Nyxoah, Medtronic, Nestl\u00e9 and L\u00f6wenstein. AM is funded by the National Institutes of Health (NIH), reports income related to medical education from Livanova, Jazz Pharmaceuticals, Zoll and Eli Lilly. ResMed provided a philanthropic donation to UC San Diego, but AM has not received personal income from ResMed or medXcloud. PC is funded by the National Health & Medical Research Council (NHMRC) of Australia. He reports having an appointment to an endowed academic Chair at the University of Sydney that was established from ResMed funding, has received research support from ResMed and SomnoMed, and is a consultant to ResMed, SomnoMed, and Sunrise Medical. AVB is an employee of ResMed. EV has no conflict of interest. MRC has no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"328"}}